Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Lyra Therapeutics Inc stock

Learn how to easily invest in Lyra Therapeutics Inc stock.

Lyra Therapeutics Inc is a biotechnology business based in the US. Lyra Therapeutics Inc shares (LYRA) are listed on the NASDAQ and all prices are listed in US Dollars. Lyra Therapeutics Inc employs 59 staff and has a trailing 12-month revenue of around $1.6 million.

How to buy Lyra Therapeutics Inc stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – LYRA. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Lyra Therapeutics Inc stock price (NASDAQ: LYRA)

Use our graph to track the performance of LYRA stocks over time.

Lyra Therapeutics Inc shares at a glance

Information last updated 2023-01-26.
Latest market close$2.67
52-week range$2.35 - $8.18
50-day moving average $3.16
200-day moving average $4.95
Wall St. target price$17.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.29

Buy Lyra Therapeutics Inc stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Lyra Therapeutics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lyra Therapeutics Inc price performance over time

Historical closes compared with the close of $2.67 from 2023-01-27

1 week (2023-01-24) -6.32%
1 month (2022-12-30) -14.97%
3 months (2022-10-31) -43.07%
6 months (2022-07-29) -58.86%
1 year (2022-01-28) -23.71%
2 years (2021-01-29) -74.74%
3 years (2020-01-27) N/A
5 years (2018-01-27) N/A

Lyra Therapeutics Inc financials

Revenue TTM $1.6 million
Gross profit TTM $-29,409,000
Return on assets TTM -36.58%
Return on equity TTM -77.86%
Profit margin 0%
Book value $2.93
Market capitalisation $88.2 million

TTM: trailing 12 months

Lyra Therapeutics Inc share dividends

We're not expecting Lyra Therapeutics Inc to pay a dividend over the next 12 months.

Lyra Therapeutics Inc share price volatility

Over the last 12 months, Lyra Therapeutics Inc's shares have ranged in value from as little as $2.35 up to $8.18. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lyra Therapeutics Inc's is -0.4224. This would suggest that Lyra Therapeutics Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Lyra Therapeutics Inc has bucked the trend.

Lyra Therapeutics Inc overview

Lyra Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018.

Frequently asked questions

What percentage of Lyra Therapeutics Inc is owned by insiders or institutions?
Currently 1.156% of Lyra Therapeutics Inc shares are held by insiders and 78.479% by institutions.
How many people work for Lyra Therapeutics Inc?
Latest data suggests 59 work at Lyra Therapeutics Inc.
When does the fiscal year end for Lyra Therapeutics Inc?
Lyra Therapeutics Inc's fiscal year ends in December.
Where is Lyra Therapeutics Inc based?
Lyra Therapeutics Inc's address is: 480 Arsenal Way, Watertown, MA, United States, 02472
What is Lyra Therapeutics Inc's ISIN number?
Lyra Therapeutics Inc's international securities identification number is: US55234L1052
What is Lyra Therapeutics Inc's CUSIP number?
Lyra Therapeutics Inc's Committee on Uniform Securities Identification Procedures number is: 55234L105

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site